NCT05742906View on ClinicalTrials.gov

CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study

NARecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Tricuspid Valve DiseaseTricuspid Valve Insufficiency
Interventions
DEVICE

Tricuspid valve replacement with the Cor TRICUSPID ECM Valve

Tricuspid valve replacement with the Cor TRICUSPID ECM Valve for the surgical management of tricuspid valve disease or dysfunction.

Trial Locations (2)

10032

RECRUITING

Columbia University Irving Medical Center/New York Presbyterian, New York

46237

RECRUITING

St Francis Hospital, Indianapolis

Sponsors
All Listed Sponsors
collaborator

Yale University

OTHER

lead

CorMatrix Cardiovascular, Inc.

INDUSTRY

NCT05742906 - CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study | Biotech Hunter | Biotech Hunter